New Study Seeks to Track ALS Progression With Smartphone App
The Muscular Dystrophy Association (MDA) is urging people with amyotrophic lateral sclerosis (ALS) to take part in a…
Articles by Diana Campelo Delgado
ALS Groups Give $1.1M More in Support of T-cell Therapy in Phase 2 Trial
Note: This story was updated April 6, 2021, to note that the study is expected to conclude late this summer,…
Cox Offers New Eye-controlled TV Remote for ALS, Other Patients
A new feature of Cox’s accessible web remote enables people with amyotrophic lateral sclerosis (ALS) and others with…
HEALEY Trial Reaches 50% Enrollment for First 3 Regimens
The HEALEY ALS platform trial, which is evaluating the safety and efficacy of several potential treatments for amyotrophic lateral…
Mitsubishi Tanabe Establishes New US Research Facility
Mitsubishi Tanabe Pharma Corporation (MTPC)Â is opening a new research site in the Boston area dedicated to discovering new therapeutic targets…
Otsuka, Eikonizo Collaborating on ALS, Rare Disease Therapies
The McQuade Center for Strategic Research and Development (MSRD)Â and Eikonizo Therapeutics have entered a collaboration to advance potential…
Coya Raises $10M to Advance T-cell Therapy Now in Phase 2 ALS Trial
Coya Therapeutics has raised $10 million in funding to advance the development of ALS001, a potential regulatory T-cell (Treg)…
Japan OKs MediciNova Patent for Ibudilast Plus Riluzole in Treating ALS
A patent application allowing MediciNova to use its investigational therapy ibudilast (MN-166) in combination with riluzole to treat people…
MTPA to Commercialize ALS Therapy Exservan in the US
Mitsubishi Tanabe Pharma America (MTPA) has entered an agreement with Aquestive Therapeutics to market Exservan, an oral film formulation…
Spinogenix Wins Grant to Advance Testing of Potential Oral Therapy
Spinogenix has been awarded a research grant from the U.S. Department of Defense (DOD) to further test its lead…